ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Kanuni Sultan Suleyman Training and Research HospitalNot yet recruiting
-
Canwell Biotech LimitedNot yet recruiting
-
Children's National Research InstituteNot yet recruitingMedulloblastoma Recurrent | Ependymoma Recurrent | Brain Tumor Recurrent | High Grade Gliomas | Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS | Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
-
BOUCHRA BENKESSOURecruiting
-
Bursa City HospitalRecruitingIgA Vasculitis | Gastrointestinal InvolvementTurkey (Türkiye)
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityNot yet recruitingMalignant Head and Neck NeoplasmUnited States
-
Far Eastern Memorial HospitalNeihu Lixin TCM ClinicRecruitingSkin Aging | Wrinkles | Facial AgingTaiwan
-
Sultan Abdulhamid Han Training and Research Hospital...Not yet recruitingPes Planus | FMSTurkey (Türkiye)
-
Surabaya State UniversityNot yet recruitingOxidative Stress | Exercise Recovery | Exercise-induced Muscle Damage | Sports Performance | Aerobic CapacityIndonesia
-
Tanta UniversityNot yet recruitingTBI (Traumatic Brain Injury) | ARDS | Fibrinogen Albumin RatioEgypt
-
South Valley UniversityNot yet recruiting
-
Robert Flavell, MD, PhDFortis Therapeutics, Inc.; Kyntra BioNot yet recruitingBladder Cancer | Advanced Solid Tumor | Nerve Sheath Neoplasms | Solid Tumor Cancer | Solid Tumor, Adult | Solid Carcinoma | Bladder Neoplasm | Solid Tumor Malignancies | Nerve Sheath Tumors | Nerve Sheath Tumor | Solid Tumor Neoplasms | Nerve Sheath Tumor, NosUnited States
Clinical Research Jobs
-
Japan - Tokyo
-
Singapore - Singapore
-
United Kingdom - Edinburgh
-
Canada - Québec - MontrealCanada - Ontario - Toronto
-
United States - North Carolina - Durham
-
Romania - New York - Cluj-Napoca
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China